The generation and actions of isoprostanes.

[1]  J. Morrow,et al.  Effect of oxygen tension on the generation of F2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes. , 1994, Biochemical pharmacology.

[2]  J. Morrow,et al.  Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism. , 1994, Methods in enzymology.

[3]  G. FitzGerald,et al.  Local Amplification of Platelet Function by 8-Epi Prostaglandin F2α Is Not Mediated by Thromboxane Receptor Isoforms* , 1996, The Journal of Biological Chemistry.

[4]  D. Murrell.  A radical proposal for the pathogenesis of scleroderma. , 1993, Journal of the American Academy of Dermatology.

[5]  J. Morrow,et al.  Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. , 1996, Arthritis and rheumatism.

[6]  J. Morrow,et al.  Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Narumiya,et al.  Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. , 1996, The Journal of clinical investigation.

[8]  K. Seibert,et al.  Isomeric prostaglandin F2 compounds arising from prostaglandin D2: a family of icosanoids produced in vivo in humans. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[9]  W. Kannel.  Update on the role of cigarette smoking in coronary artery disease. , 1981, American heart journal.

[10]  R. Doll,et al.  Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. , 1978, Journal of epidemiology and community health.

[11]  W. Mathews,et al.  Quantitation of hydroperoxy-eicosatetraenoic acids and hydroxy-eicosatetraenoic acids as indicators of lipid peroxidation using gas chromatography-mass spectrometry. , 1993, Analytical biochemistry.

[12]  J. Morrow,et al.  Evidence that the F2-isoprostane, 8-epi-prostaglandin F2α, is formed in vivo , 1994 .

[13]  J. Morrow,et al.  The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. , 1992, Prostaglandins.

[14]  J. Morrow,et al.  Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. , 1995, The New England journal of medicine.

[15]  B. Halliwell,et al.  The measurement of free radical reactions in humans , 1987, FEBS letters.

[16]  J. Morrow,et al.  Diisopropylphosphorofluoridate-induced muscle hyperactivity associated with enhanced lipid peroxidation in vivo. , 1996, Biochemical pharmacology.

[17]  J. Morrow,et al.  Actions of the E2-isoprostane, 8-ISO-PGE2, on the platelet thromboxane/endoperoxide receptor in humans and rats: additional evidence for the existence of a unique isoprostane receptor. , 1994, Prostaglandins.

[18]  D. Nugteren,et al.  Isolation and properties of intermediates in prostaglandin biosynthesis. , 1973, Biochimica et biophysica acta.

[19]  P. Reaven,et al.  Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[20]  J. Oates,et al.  Urinary prostaglandins. Identification and origin. , 1975, The Journal of clinical investigation.

[21]  J. Morrow,et al.  A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Harman,et al.  The aging process. , 1981, Basic life sciences.

[23]  J. Morrow,et al.  Nonenzymatic Free Radical-catalyzed Generation of Thromboxane-like Compounds (Isothromboxanes) in Vivo* , 1996, The Journal of Biological Chemistry.

[24]  E. D. Mihelich,et al.  Stereochemical course of the autooxidative cyclization of lipid hydroperoxides to prostaglandin-like bicyclic endoperoxides , 1984 .

[25]  A. Dabbagh,et al.  The effect of iron overload on rat plasma and liver oxidant status in vivo. , 1994, The Biochemical journal.

[26]  J. Morrow,et al.  Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. , 1992, The Journal of clinical investigation.

[27]  L. J. Roberts II,et al.  Demonstration of halothane-induced hepatic lipid peroxidation in rats by quantification of F2-isoprostanes. , 1996, Anesthesiology.

[28]  J. Morrow,et al.  Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. , 1990, Analytical biochemistry.

[29]  J. Morrow,et al.  Identification of the Major Urinary Metabolite of the F2-isoprostane 8-Iso-prostaglandin F2α in Humans* , 1996, The Journal of Biological Chemistry.

[30]  J. Morrow,et al.  Cyclosporine-induced alterations in renal function are not associated with lipid peroxidation. , 1994, Transplantation.

[31]  H. Jaeschke,et al.  Lipid peroxidation as molecular mechanism of liver cell injury during reperfusion after ischemia. , 1994, Free radical biology & medicine.

[32]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[33]  S. Nakanishi,et al.  Cloning and expression of cDNA for a human thromboxane A2 receptor , 1991, Nature.

[34]  M. Baraldi,et al.  Measurement of urinary 8-Epi-prostaglandin F2alpha, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction/gas chromatography-mass spectrometry. Basal levels in smokers and nonsmokers. , 1996, Free radical biology & medicine.

[35]  M. Hecker,et al.  Identification of novel arachidonic acid metabolites formed by prostaglandin H synthase. , 1987, European journal of biochemistry.

[36]  G. FitzGerald,et al.  Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. , 1996, The Journal of biological chemistry.

[37]  M. Cousins,et al.  Genetic Differences in Reductive Metabolism and Hepatotoxicity of Halothane in Three Rat Strains , 1981, Anesthesiology.

[38]  J. Morrow,et al.  Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors. , 1992, The Journal of clinical investigation.

[39]  K. Badr,et al.  Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. , 1992, The New England journal of medicine.

[40]  J. Morrow,et al.  The isoprostanes. Current knowledge and directions for future research. , 1996, Biochemical pharmacology.

[41]  G. FitzGerald,et al.  Cylooxygenase-dependent Formation of the Isoprostane, 8-Epi Prostaglandin F2α(*) , 1995, The Journal of Biological Chemistry.